Cyclic hiv principal neutralizing determinant peptides

Details Cyclic hiv principal neutralizing determinant peptides Cyclic hiv principal neutralizing determinant peptides

C - Chemistry, Metallurgy

07

K

C07K 14/155 (2006.01) C07K 1/06 (2006.01) C07K 14/16 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2047042

43/GHB10 PATENT 18150 TITLE OF THE INVENTION CYCLIC HIV PRINCIPAL NEUTRALIZING DETERMINANT PEPTIDES ABSTRACT OF THE DISCLOSURE Human Immunodeficiency Virus (HIV) Principal Neutralizing Determinant (PND) peptides, or peptides immunologically equivalent therewith, having the structure: Image 43/GHB10 PATENT 18150 - i - wherein the ring system contains stable thioether bonds, are useful as analytical tools, as reagents in ELISA assays, or as reagents for making covalent conjugate immunogens. Conjugates containing these stable, cyclic peptides are useful for raising mammalian anti-peptide, anti-HIV, or HIV-neutralizing immune responses, and a composition containing such a conjugate may be used as a vaccine to prevent HIV disease, including Acquired Immune Deficiency Syndrome, (AIDS), or AIDS related complex, (ARC), or as an immunogen for treating humans afflicted with AIDS or ARC.

Affiliated with

Also associated with

Rating

Cyclic hiv principal neutralizing determinant peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic hiv principal neutralizing determinant peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic hiv principal neutralizing determinant peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1389301